MARATTO

erratum · Pharmaceuticals

Correction: Awaji et al. Chemotherapeutic Activity of Imidazolium-Supported Pd(II) o-Vanillylidene Diaminocyclohexane Complexes Immobilized in Nanolipid as Inhibitors for HER2/neu and FGFR2/FGF2 Axis Overexpression in Breast Cancer Cells. Pharmaceuticals 2023, 16, 1711

2025Open accessSuez University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

In the original publication [...].

Research topics

  • HER2/EGFR in Cancer Research
  • Protein Tyrosine Phosphatases
  • Lung Cancer Treatments and Mutations

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3390/ph18091287

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.